Longevity Health Holdings, Inc.
XAGE
$0.21
-$0.01-5.83%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.07% | -17.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.07% | -17.17% | |||
| Cost of Revenue | -43.26% | 60.46% | |||
| Gross Profit | 387.84% | -84.13% | |||
| SG&A Expenses | -41.61% | -38.19% | |||
| Depreciation & Amortization | -11.33% | -7.98% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.53% | -30.50% | |||
| Operating Income | 49.97% | 33.25% | |||
| Income Before Tax | -31.54% | 30.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.54% | 31.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.54% | 31.27% | |||
| EBIT | 49.97% | 33.25% | |||
| EBITDA | 50.35% | 33.44% | |||
| EPS Basic | -0.96% | 35.41% | |||
| Normalized Basic EPS | 61.56% | 32.91% | |||
| EPS Diluted | -0.96% | 35.41% | |||
| Normalized Diluted EPS | 61.56% | 32.91% | |||
| Average Basic Shares Outstanding | 30.29% | 6.40% | |||
| Average Diluted Shares Outstanding | 30.29% | 6.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||